121 – 130 of 173
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Prediagnostic telomere length and risk of B-cell lymphoma-Results from the EPIC cohort study
(
- Contribution to journal › Article
-
Mark
Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
(
- Contribution to journal › Article
-
Mark
Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer.
(
- Contribution to journal › Article
-
Mark
The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy.
(
- Contribution to journal › Article
-
Mark
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
(
- Contribution to journal › Article
-
Mark
t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma
(
- Contribution to journal › Article
-
Mark
37p * androgen receptor expression in a population-based prospective breast cancer cohort.
(
- Contribution to journal › Published meeting abstract
-
Mark
71p * statin-induced anti-proliferative effects via cyclin d1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer.
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
(
- Contribution to journal › Article